Efficacy and Safety of Molnupiravir for the Treatment of Non-Hospitalized Adults With Mild COVID-19: A Randomized, Open-Label, Parallel-Group Phase 3 Trial

SSRN Electronic Journal (2022) - Comments
doi: 10.2139/ssrn.4042673 issn: 1556-5068

Sudhakar Koudinya Tippabhotla, Dr. Subhra Lahiri, Rama Raju D, Chandrashekhar Kandi, Naga Prasad V